Literature DB >> 17258458

Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors.

Frank Rong1, Suetying Chow, Shunqi Yan, Gary Larson, Zhi Hong, Jim Wu.   

Abstract

From chemical compound library screening using an HCV NS5B RNA-dependent RNA polymerase enzymatic assay, we identified a substituted quinoxaline hit with an IC(50) of 5.5 microM. A series of substituted quinoxaline amide derivatives were synthesized based on the hit's pharmacophore, and a good structure-activity relationship was observed. Computer modeling analysis was employed to help comprehend the SAR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17258458     DOI: 10.1016/j.bmcl.2006.12.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Studies of new peroxyoxalate-H2O2 chemiluminescence system using quinoxaline derivatives as green fluorophores.

Authors:  Abdolraouf Samadi-Maybodi; Reza Akhoondi; Mohammad Javad Chaichi
Journal:  J Fluoresc       Date:  2010-03-10       Impact factor: 2.217

2.  Multidimensional Screening and Methodology Development for Condensations Involving Complex 1,2-Diketones.

Authors:  John R Goodell; Bo Leng; Tracy K Snyder; Aaron B Beeler; John A Porco
Journal:  Synthesis (Stuttg)       Date:  2010-07-01       Impact factor: 3.157

3.  Pd/C-catalyzed, copper-free Sonogashira coupling: one-pot synthesis of 1-aryl-4-(2-phenylethynyl)[1,2,4]triazolo[4,3-a]quinoxalines in water.

Authors:  Mohammad Bakherad; Saeideh Jajarmi
Journal:  Monatsh Chem       Date:  2013-02-14       Impact factor: 1.451

4.  Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.

Authors:  Lei You; Eun Jeong Cho; John Leavitt; Li-Chung Ma; Gaetano T Montelione; Eric V Anslyn; Robert M Krug; Andrew Ellington; Jon D Robertus
Journal:  Bioorg Med Chem Lett       Date:  2011-03-17       Impact factor: 2.823

5.  Highly efficient synthesis of quinoxaline derivatives from 1,2-benzenediamine and α-aminoxylated 1,3-dicarbonyl compounds.

Authors:  Jianwei Yan; Yanhong Xu; Fangfang Zhuang; Jie Tian; Guisheng Zhang
Journal:  Mol Divers       Date:  2016-01-21       Impact factor: 2.943

6.  Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.

Authors:  Tanaji T Talele; Payal Arora; Shridhar S Kulkarni; Maulik R Patel; Satyakam Singh; Maksim Chudayeu; Neerja Kaushik-Basu
Journal:  Bioorg Med Chem       Date:  2010-05-15       Impact factor: 3.641

7.  Construction of a novel quinoxaline as a new class of Nrf2 activator.

Authors:  Murugesh Kandasamy; Kit-Kay Mak; Thangaraj Devadoss; Punniyakoti Veeraveedu Thanikachalam; Raghavendra Sakirolla; Hira Choudhury; Mallikarjuna Rao Pichika
Journal:  BMC Chem       Date:  2019-09-24

8.  Natural vs. Synthetic Phosphate as Efficient Heterogeneous Compounds for Synthesis of Quinoxalines.

Authors:  Abbas Amini; Azadeh Fallah; Ahmad Sedaghat; Ahmad Gholami; Chun Cheng; Anju R Gupta
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.